Cyblex MV 80.3 Tablet
By Cyblex MV
Rx
15 Tablet in a Strip

Composition
Voglibose(0.3mg) + Metformin(500mg) + Gliclazide(80mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
July, 2027

liver
When using Sulfozid-MV 80.3 Tablet, it's important to be cautious if you have liver disease. Your doctor may need to adjust the dosage of the tablet based on your condition. For patients with mild to moderate liver disease, it's typical to start with a low dose of Sulfozid-MV 80.3 Tablet. However, the use of this tablet is not advised for individuals with severe liver disease. Always consult your doctor for personalized guidance on how to proceed with Sulfozid-MV 80.3 Tablet if you have liver issues.

kidney
Sulfozid-MV 80.3 Tablet should be used cautiously in patients with kidney disease. Adjustments in dosage may be necessary, and consultation with a doctor is recommended. Avoid use in severe kidney disease; monitor kidney function regularly during treatment.

alcohol
It is not safe to drink alcohol while taking Sulfozid-MV 80.3 Tablet.

driving
When taking Sulfozid-MV 80.3 Tablet, if you experience symptoms of low or high blood sugar, avoid driving as it can impact your ability to drive safely.

pregnancy
During pregnancy, Sulfozid-MV 80.3 Tablet may not be safe to use. Limited human studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. It is important to consult your doctor regarding its use in pregnancy.

breastfeeding
During breastfeeding, caution is advised when using Sulfozid-MV 80.3 Tablet. It is recommended to pause breastfeeding until the mother's treatment is finished and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹280.1
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024